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Abstract 
 
Piscine myocarditis virus (PCMV) is a double-stranded RNA virus structurally similar to the 
Totiviridae family. PCMV is the causative agent of cardiomyopathy syndrome (CMS), a severe cardiac 
disease that affects farmed Atlantic salmon (Salmo salar). A recent study characterized the host 
immune response in infected salmon through a transcriptome immune profiling, which confirmed 
a high regulation of immune and anti-viral genes throughout infection with PCMV. Previously we 
developed a novel model based on repeated non-lethal blood sampling, enabling the individual 
monitoring of salmonids during an infection. In the present work, we used this model to describe 
the host immune response in the blood cells of Atlantic salmon after intramuscular infection with 
PCMV-containing tissue homogenate over a 77-day period. At the final stage heart samples were 
also collected to verify the PCMV load, the pathological impact of infection and to compare the 
transcript profiles to blood. The expression level of a range of key immune genes was determined 
in the blood and heart samples by real-time PCR. Results indicated selected immune genes (mx, 
cd8α and γip) were up-regulated in the heart tissue of infected animals at the terminal time point, 
in comparison to the non-infected fish. When analyzing the blood samples over the course of 
infection, a significant n up-regulation of mx gene was also observed. The time and number of peaks 
in the kinetics of expression was different between individuals. The PCMV load and CMS pathology 
was verified by real-time PCR and histopathology, respectively. No pathogen and no pathology could 
be detected during the course of the experiment except at the terminal stage (viral load by qPCR 
and pathology by histology). This study emphasizes the value of non-lethal monitoring for evaluating 
the health status of fish at early stages of infection and in the absence of clinical signs. 
 
Keywords: Non-lethal sampling; immune response; Atlantic salmon; PMCV; 3Rs; mx; interferon
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1. Introduction 
Animal infectiology experiments are traditionally carried out by culling animals regularly 
during the course of infection. The accuracy of the description of the host response to a live 
pathogen or a treatment suffers from the underlying assumption that a population of animals reacts 
in a similar manner to each other. A novel model based on single animal analysis in which repeated 
non-lethal blood samples are collected and used to describe the response was developed previously 
for a fast-developing viral disease (Infectious Salmon Anaemia, Collet et al., 2015). In the present 
article we used this model for a slower developing disease Cardiomyopathy Syndrome (CMS), 
characterised by a severe cardiac inflammation that affects Atlantic salmon (Salmo salar) (Rodger 
and Turnbull, 2000; Garseth et al., 2017).  The causative agent of CMS is the piscine myocarditis 
virus (PCMV), a double-stranded RNA virus structurally similar to the Totiviridae family (Haugland et 
al, 2011). A recent study characterized the host immune response in infected salmon through a 
transcriptome immune profiling, which confirmed a high regulation of immune and anti-viral genes 
throughout infection with PCMV (Timmerhaus et al, 2011). Taking into account the above findings, 
we applied the non-lethal blood sampling method, enabling for the first time the individual 
monitoring of Atlantic salmon during an infection with CMS after intramuscular infection with PCMV 
over a 77-day period. A range of key immune genes was monitored during infection, by real-time 
PCR, in both blood and terminal heart tissues. The PCMV load and CMS pathology was verified by 
real-time PCR and histopathology. This study confirms the importance of using a non-lethal sampling 
method in order to individually monitor the host response throughout infection with a chronic 
disease such as CMS. 
 
2. Material and methods 
2.1. Experimental design 
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This study was carried out in strict accordance with the UK Animals (Scientific Procedures) 
Act 1986 (ASPA) under project licence PPL3965. The protocol was approved by the Marine Scotland 
Ethical Review Committee. All procedures were performed under MS222 anaesthesia, and all efforts 
were made to minimise suffering. Twenty PIT tagged Atlantic salmon Salmo salar were provided by 
Landcatch Natural Selection (Hendrix-Genetics), transported to the Aquarium Facility at Marine 
Scotland and divided equally into two circular 1 m3 tanks. The fish were screened for common 
pathogens, viral hemorrhagic septicaemia virus, infectious pancreatic necrosis virus, infectious 
salmon anemia virus, infectious hematopoietic necrosis virus, and Aeromonas salmonicida using 
standard methods in the laboratory (Collet et al. 2015). They were kept under natural photoperiod 
(October), sea water salinity 37 ‰ and at 10 °C. They were fed once a day with pellets (EWOS). After 
a week of acclimation, all the fish were anaesthetised, weighed (average weight 1,109 ± 167 g) and 
injected intra-muscularly with 100 µl heart tissue homogenate from salmon originating from a 
clinical case of CMS on the north-west coast of Norway and diagnosed with a piscine myocarditis 
virus infection by real-time PCR and with typical histo-morphological heart changes (N=10, 1 tank) 
or 100 µl tissue homogenate from healthy salmon (N=10, 1 tank). The PMCV-positive homogenate 
was tested earlier to yield high levels of PMCV genome in heart tested by real-time PCR (Haugland 
et al. 2010). The sampling model was as described by Collet et al. (2015). Immediately before 
injection, a small blood sample (150 µl) was collected from the caudal vein (Pre-infection bleed). 
Subsequently, non-lethal blood samples were collected repeatedly at 4, 8, 12, 16, 28, 35, 42, 49, 56, 
63, 70, and 77 days post infection (dpi). At 77 dpi all the fish were killed by exposure to an overdose 
of anaesthetic and blood collected immediately. For all samples, the blood was centrifuged for 30 
sec at 10,000g to separate blood cells and plasma, and stored at -80°C until processed further. Heart 
tissue was dissected and half was stored in 750 µl RNAlater (Sigma) at -80°C for subsequent viral 
load analysis and the other half was fixed in 10% phosphate buffered formalin, embedded in paraffin 
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wax, sectioned at 3-4 micrometres and stained with haematoxylin and eosin for histopathology 
analysis. 
2.2. RNA extraction, cDNA synthesis and real-time PCR 
RNA purification and cDNA synthesis from whole blood cells and heart tissue was carried 
out using a method described by Collet et al. (2015). Real-time PCR analysis was performed for the 
house keeping gene ef1α, PCMV using forward primer 5’-TTCCAAACAATTCGAGAAGCG-3’, reverse 
primer 5’-ACCTGCCATTTTCCCCTCTT-3’ and Taqman probe 5’-6FAM-CCGGGTAAAGTATTTGCGTC-3’. 
(amplicon 141 nt, accession number NC_015639), and immune genes (mx, cd8α and γip), as 
described by Collet et al. (2015). 
 
2.3. Histopathology analysis. 
Heart samples (n=18) collected at 77 days post challenge were examined for pathological 
changes by light microscopy. Histopathological changes in heart sections were scored as described 
by Haugland et al. (2011), and recorded on a visual analogue scale (0-4).  
2.4 Statistical analysis 
The histopathological scores for the non-infected and infected groups were analyzed by a 
Kruskal-Wallis test, with p < 0.05 considered statistically significant when comparing groups. The 
comparisons of the gene expression levels between infected and control groups at the terminal 
time-point (heart tissues) was carried out using a T-test. Statistical significance was taken as a P 
value of <0.05. 
The set of data generated from repeated blood sampling was analysed using a method 
developed in R software package by Collet et al. (2015). 
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3. Results and discussion 
When analysing the expression of mx, cd8α and γip genes in the heart tissue of Atlantic 
salmon, results showed a significant upregulation (P < 0.05) of all genes in the PCMV infected group 
(in comparison to the non-infected group) at the terminal time point (77-days post infection) (Figure 
1A). Moreover, at day 77 qPCR detected PMCV with Cp values ranging from 16.57 to 28.17, with an 
average Cp of 21.70. None of the un-infected control fish showed any sign of amplification. 
Expression analysis of the PCMV load in both infected and non-infected groups is shown in Figure 
1B (p < 0.05). No amplification of PMCV occurred from blood cells cDNA collected from fish during 
the infection (results not shown). To confirm the expression analysis data, heart tissues from the 
terminal time-point were also subjected to histopathological examination (Figures 1C-D). Results 
confirmed that control fish (Fish 1 to 10, samples examined from 9 fish) had an overall score of 1 or 
below representing non-specific inflammatory changes in the heart tissue (Figure 1C). The infected 
group (Fish 11 to 20, n=9 examined) had scores that went up to 3 (Table 1). In more detail, control 
fish revealed a mild myocarditis typified by sub-endothelial inflammation of inflammatory cells, with 
no degenerative changes observed (Figure 1C), and considered a non-specific inflammation of 
unknown cause. When analysing the spongious part of the cardiac ventricle of PCMV-infected 
Atlantic salmon (Figure 1D), diffuse infiltration of cardiomyocytes with inflammatory cells was seen, 
dominated by lymphocytes and some macrophages. Inflammatory cells were seen in the 
sarcoplasm, beneath endothelial cells and attached to the endothelium. A distinct degeneration of 
cardiomyocytes was also observed (Figure 1D, 1B). The score difference between controls and 
infected fish was analysed by the Kruskal-Wallis rank test and gave p=0.034 and p=0.021 for atrium 
and ventricle, respectively. 
During the 77-day infection period, small blood samples were collected before the infection 
(pre-infection bleed, Day 0) and at different time points post infection (Days 4, 8, 12, 16, 28, 35, 42, 
49, 56, 63, 70 and 77). From the expression data obtained using the terminal heart tissues, we 
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observed that mx showed a high expression at day 77 post-infection by real-time PCR. In the blood 
cells mx gene was significantly induced. Figure 2A shows the individual kinetics of mx expression in 
the 10 control and 10 infected fish over the time of infection. In spite of a large variability between 
individuals, the majority of the gene expression levels in the infected animals were above those in 
the un-infected control animals. The overall effect of infection on the mx gene transcript level was 
statistically significant as analysed according to the method outlined in Collet et al. (2015) . A 
detailed look at the individual kinetics (Figure 2B) reveals that some animals had a peak of mx 
expression at 8 dpi (Fish 20, Figure 2B), some at 8 and 50 dpi (Fish 12, Figure 2B), indicating that 
animals under controlled experimental infection (by injection) are not synchronous. The lethal 
sampling procedure used traditionally in fish infectiology is unable to resolve this individual 
variability. 
This is the first time that individual fish have been monitored during experimental infection 
with material containing the infectious agent for Cardiomyopathy Syndrome, PMCV. We have 
previously developed a non-lethal sampling method for salmonid fish (Urquhart et al., 2016) and 
applied it to viral (Collet et al., 2015), bacterial (Monte et al., 2016) and ectoparasitic (Chance et al., 
2018) infection models. Monitoring the same animal over time allows an improvement in the data 
output by considering the inter-individual variability and with the use of fewer animals (Hall et al., 
2018). 
The present infection model concerns the Cardiomyopathy Syndrome, a slow progressing 
disease not leading to any mortality. Although we cannot be guaranteed that the infected fish do 
not have an additional ubiquitous viral infection, the terminal viral load in the heart tissue is high 
with an average Ct value of 21.7 and the clinical signs, as assessed by histopathology examination, 
are characteristic of CMS. 
The resolution of the sampling regime was made up of 12 time points every four days within 
the first two weeks and then every week for 11 weeks. Timmerhaus et al. (2011, 2012) used a lethal 
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experimental challenge with sampling at weeks 2, 4, 6, 8, 9, 10, 11 and 12 and the most severe 
histopathology conditions were detected at weeks 8-9. The highest viral load detected was between 
weeks 8-10 in the heart tissue. PMCV could be detected in blood cells but this was the lowest viral 
load found compared with heart, spleen or head kidney tissues. CD8 beta chain expression level was 
found at a later stage of infection in agreement with our findings of CD8 alpha in the heart tissue, 
assuming co-expression of the two chains alpha and beta. These kinetic of infection were in 
agreement with Haugland et al. (2011). 
In the blood, the virus was detected at 4- and 8-weeks post-infection in the Timmerhaus et 
al. (2011) study but only at low levels compared to those found in the spleen or heart tissues for the 
same time points. In the present study, we could no detect any virus in the whole blood cells by 
qPCR at any of the time points. This may be explained by a difference in the sensitivity of the qPCR 
assays used and/or in the amount of material analysed. Alternatively, the virus may have replicated 
at early stage in a tissue responsible for a release of interferon in the blood stream, in turn inducing 
mx gene in some blood cells. 
We demonstrate here the possibility to monitor the immune response of infected individual 
animals under experimental conditions in a situation where the pathogen could not be detected, 
the animals did not show any external sign of disease and no mortality occurred. The final lethal 
sampling revealed a high viral load and a clear development of CMS symptoms. Nevertheless, the 
immune response was evident from a very early time point and could be monitored by qPCR in 
blood cells acquired non-lethally. The viraemia phase is most common route of dissemination of 
viral infection within the organism (Baron et al., 1996) and is often preclinical. If viremia correlates 
well to the intensity of later clinical symptoms, this can help to predict the intensity of a viral 
infection before the onset of clinical signs. Therefore, early blood immune parameters can be 
valuable welfare indicators, in addition to the evident robustness of individual longitudinal data 
made possible by the non-lethal sampling method. It is important to note that the route of infection 
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by injection was chosen to secure a successful outcome of infection, and thus the high prevalence 
it provides, especially for a small group of ten animals. However, cohabitation challenge would be 
preferable and would mimic natural infection processes/routes but with the limited horizontal 
spread of infection under experimental conditions (Haugland et al., 2011) would require a larger 
number of animals being included. In addition to the benefit from an animal welfare perspective 
(use of fewer animals), this infectiology method also allows for rigorous validation of the Koch’s 
postulate. Ultimately this model could be used to assess, through the immune response, livestock’ 
health status at the pre-clinical stage of infection. 
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Figure legends 
Figure 1. Analysis of tissues collected at the final time-point (77 days post-infection) from non-
infected individuals (control group) and piscine myocarditis virus (PCMV) infected individuals 
(infected group). A. Expression analysis of selected immune genes (mx, cd8 and γip) in Atlantic 
salmon infected or non-infected (control) with PCMV pathogen 77-days post-infection. RNA was 
collected for real-time PCR expression analysis and results are expressed as averages (n= 10 fish per 
group). Statistically significant results between infected and non-infected groups are indicated by 
an asterisk (*), where P < 0.05. B. Viral load was detected by performing a qPCR in the heart of the 
non-infected and infected salmon, quantifying PCMV and normalising it to the house-keeping gene 
EF1a. Statistically significant results (paired t test) between infected and non-infected groups are 
indicated by an asterisk (*), where P < 0.05. C. Cardiac ventricle of non-infected salmon at day 77 
post-infection showing a non-specific inflammatory focus with mild endothelial cell reaction (HE 
stain). D. Cardiac ventricle of a PCMV-infected salmon at day 77 post-infection, showing strong 
inflammatory reaction with infiltration of lymphocytes and some macrophages in the 
cardiomyocytes (sarcoplasma) and with strong endothelial hypertrophy and hyperplasia (HE stain). 
E. Summary of atrium (a) and ventricle (v) scores in the control group and in the infected fish. Atrium 
shows the highest score while the percent non-affected fish (score of 0) is highest in the atrium 
compared to ventricle. By Kruskal-Wallis rank test atrium and ventricle scores of infected fish were 
significantly higher than controls, 0.034 and 0.021, respectively.  
Figure 2. Individual mx gene expression level in the cells of blood collected from non-infected and 
PCMV-infected Atlantic salmon over a 77-day infection gene expression. Data represent the 
individual fold change relative to pre-infection (day 0) (1 line = 1 animal) in n=10 (blue lines) non-
infected and n = 10 (red lines) infected animals (A) or in two (Fish 12 and 20) infected animals (B). 
Some of the kinetics are incomplete as a discrete number of samples were lost.  
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Table 1. Scoring histopathological examination in heart 
 
Fish ID Atrium Ventricle Epicard 
1 0 0 0 
2 0 0 0 
3 1 1 1 
4 0 0 0 
5 1 1.2 0 
6    
7 0 0 0 
8 0.5 0.5 0 
9 0 0 0 
10 0 0 0 
11 0 0.7 0 
12 2.3 2 0 
13 2 1.3 0 
14 3 2.2 0 
15 2.2 2 0 
16    
17 0 1 0 
18 0 0 0 
19 2.5 2.4 0 
20 1.2 0 0 
 
Note: Fish 1 to 10 are non-infected fish (control), Fish 11 to 20 are PCMV-infected fish 
 
 
 
